AIRNA
Victor De Jesus is an experienced Associate Scientist at AIRNA since March 2024, following a role as Principal Associate Scientist at Ikena Oncology from August 2021 to March 2024, where robust pharmacological data packages for novel small molecule compounds were produced. Prior positions include Senior In Vivo Associate at both Servier Pharmaceuticals (April 2021 - August 2021) and Agios Pharmaceuticals (May 2012 - April 2021), contributing to the cross-functional planning, design, and execution of in vivo experiments that played a significant role in the FDA approval of IDHIFA®, TIBSOVO®, and PYRUKYND®. Victor's career began as a Vivarium Technician at Charles River Laboratories (2009 - 2012). Academic background includes an Associate's degree in Biology from Middlesex Community College (2013 - 2015) and a Bachelor's degree in Graphic Communications from The New England Institute of Art (2002 - 2006).
This person is not in any teams
AIRNA
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA editing therapeutics driven by its powerful and flexible RNA editing platform, RESTORE+.